(Approval lapsed) Estradot 50 estradiol 50 microgram transdermal drug delivery system 8 pack
Section 19A approved medicine
(Approval lapsed) Estradot 50 estradiol 50 microgram transdermal drug delivery system 8 pack
Section 19A approval holder
Novartis Pharmaceuticals Australia Pty Ltd ABN 18 004 244 160
Phone
1800 671 203
Approved until
Status
Expired
Medicines in short supply/unavailable
ESTRADOT 50 estradiol 50 microgram transdermal drug delivery system sachet - ARTG 97564
Indication(s)
Short term oestrogen replacement therapy for the treatment of the symptoms of natural or surgically induced menopause. In women with an intact uterus, oestrogens should always be supplemented by administration of a progestogen.